Cho Hee Yeon
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean J Pediatr. 2012 Jan;55(1):1-5. doi: 10.3345/kjp.2012.55.1.1. Epub 2012 Jan 31.
The need for evidence-based decision making in immunization programs has increased due to the presence of multiple health priorities, limited human resources, expensive vaccines, and limited funds. Countries should establish a group of national experts to advise their Ministries of Health. So far, many nations have formed their own National Immunization Technical Advisory Groups (NITAGs). In the Republic of Korea, the Korea Expert Committee on Immunization Practices (KECIP), established by law in the early 1990s, has made many important technical recommendations to contribute to the decline in vaccine preventable diseases and currently functions as a NITAG. It includes 13 core members and 2 non-core members, including a chairperson. Core members usually come from affiliated organizations in internal medicine, pediatrics, obstetrics, microbiology, preventive medicine, nursing and a representative from a consumer group, all of whom serve two year terms. Non-core members comprise two government officials belonging to the Korea Centers for Disease Control and Prevention (KCDC) and the Korea Food and Drug Administration. Meetings are held as needed, but at least twice a year, and sub-committees are formed as a resource for gathering, analyzing, and preparing information for the KECIP meetings. Once the sub-committees or the KCDC review the available data, the KECIP members discuss each issue in depth and develop recommendations, usually by a consensus in the meeting. The KECIP publishes national guidelines and immunization schedules that are updated regularly. KECIP's role is essentially consultative and the implementation of their recommendations may depend on the budget or current laws.
由于存在多个卫生重点事项、人力资源有限、疫苗昂贵以及资金有限,免疫规划中基于证据的决策需求有所增加。各国应设立一组国家专家,为其卫生部提供建议。到目前为止,许多国家已经组建了自己的国家免疫技术咨询小组(NITAGs)。在大韩民国,20世纪90年代初依法设立的韩国免疫实践专家委员会(KECIP),为疫苗可预防疾病的减少做出了许多重要技术建议,目前作为一个NITAG发挥作用。它包括13名核心成员和2名非核心成员,包括一名主席。核心成员通常来自内科、儿科、产科、微生物学、预防医学、护理等附属机构以及一名消费者团体代表,他们的任期均为两年。非核心成员包括两名隶属于韩国疾病控制与预防中心(KCDC)和韩国食品药品管理局的政府官员。会议根据需要召开,但每年至少两次,并成立小组委员会,作为为KECIP会议收集、分析和准备信息的资源。一旦小组委员会或KCDC审查了现有数据,KECIP成员就会深入讨论每个问题并制定建议,通常在会议上以协商一致的方式进行。KECIP发布定期更新的国家指南和免疫规划时间表。KECIP的作用本质上是咨询性的,其建议的实施可能取决于预算或现行法律。